Insight Molecular Diagnostics Inc. (IMDX) earnings · rev $4.1M
These earnings events as JSON? API free 100/dayInsight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
This IMDX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported IMDX revenue for 2025-12-31 was $4.1M. Net income was -$50.2M. Revenue was up 115.6% from 2024-12-31 to 2025-12-31. IMDX currently screens at market cap $117.1M.
When the next IMDX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 115.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full IMDX research stays on the stock page; the tape stays on the quote page.
IMDX earnings FAQ
What are IMDX's latest revenue and net income?
Latest cached Insight Molecular Diagnostics Inc. (IMDX) revenue for Dec 31, 2025 was $4.1M. Net income was -$50.2M. Statements: https://lician.com/financials/imdx
What is IMDX's latest diluted EPS?
Latest cached Insight Molecular Diagnostics Inc. (IMDX) diluted EPS for Dec 31, 2025 was -$1.65.
What period does the latest IMDX earnings print cover?
The latest cached Insight Molecular Diagnostics Inc. (IMDX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did IMDX revenue change from the prior cached period?
Cached Insight Molecular Diagnostics Inc. (IMDX) revenue was up 115.6% from $1.9M (Dec 31, 2024) to $4.1M (Dec 31, 2025). Statements: https://lician.com/financials/imdx
Where are IMDX earnings listed?
Cached earnings facts for Insight Molecular Diagnostics Inc. (IMDX) are listed at https://lician.com/earnings/imdx. Statements: https://lician.com/financials/imdx
Not investment advice.